Katy, TX, United States of America

Christine Weathers

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Amgen Inc.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christine Weathers. Retrieved from https://idiyas.com/inventor/christine-weathers

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 31.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christine Weathers: Innovator in Cancer Treatment

Introduction

Christine Weathers is a notable inventor based in Katy, TX (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic agents.

Latest Patents

Christine holds 1 patent for her invention titled "Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer." This patent provides MDM2 inhibitor compounds of Formula I or II, or the pharmaceutically acceptable salts thereof. These compounds are particularly useful as therapeutic agents for the treatment of various cancers. Additionally, her invention relates to pharmaceutical compositions that contain an MDM2 inhibitor.

Career Highlights

Christine is currently employed at Amgen Inc., a leading biotechnology company. Her work focuses on developing innovative solutions to combat cancer, showcasing her dedication to improving patient outcomes.

Collaborations

Some of her notable coworkers include Michael D Bartberger and Hilary Plake Beck, who contribute to the collaborative efforts in research and development at Amgen Inc.

Conclusion

Christine Weathers is a pioneering inventor whose work in developing MDM2 inhibitors represents a significant advancement in cancer treatment. Her contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…